The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes

Diabetic Medicine

Volumn 22, Issue 10, 2005, Pages 1321-1325

  Ainla, Tiia ^a,b   Baburin, A ^c,d   Teesalu, R ^a,b   Rahu, M ^c,d  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY CLINICS   (Estonia)

^c NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^d UNIVERSITY OF TARTU   (Estonia)

Author keywords

Acute myocardial infarction; Diabetes; Hyperglycaemia; Mortality

Indexed keywords

GLUCOSE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ESTONIA; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; REGISTER; RESUSCITATION;

AGED; BLOOD GLUCOSE; DIABETIC ANGIOPATHIES; FEMALE; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; MALE; MYOCARDIAL INFARCTION;

EID: 25844462830     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01625.x     Document Type: Article

References (21)

1. Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003; 89: 512-516.
2. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: 1748-1754.
3. Bolk J, van der Ploeg TJ, Cornel JH, Arnold AER, Sepers J, Umans VAWM. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001; 79: 207-214.
4. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-778.
5. Norhammar AM, Rydén L, Malmberg K. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22: 1827-1831.
6. Yudkin JS, Oswald GA. Hyperglycaemia, diabetes and myocardial infarction. Diabet Med 1987; 4: 13-18.
7. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischemia and arrhytmias. Lancet 1994; 343: 155-158.
8. Vetter NJ, Adams W, Strange RC, Oliver MF. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974; 303: 284-289.
9. Malmberg K, Rydén L, Hamsten A, Herlitz J, Waldenström A, Wedel H. Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. Cardiovas Res 1997; 34: 248-253.
10. Diaz R, Paolasso EC, Piegas LS, Tajer CD, Moreno MG, Corvalan R et al. Metabolic modulation of acute myocardial infarction. The ECLA Glucose-Insulin-Potassium Pilot Trial. Circulation 1998; 98: 2227-2234.
11. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-982.
12. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000; 21: 1502-1513.
13. Stata. User's Guide. College Station, TX: Stata Press 1997.
14. Oswald GA, Corcoran S, Yudkin JS. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984; 323: 1264-1267.
15. Tenerz Å, Lönnberg I, Berne C, Nilsson G, Leppert J. Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J 2001; 22: 1102-1110.
16. Tenerz Å, Nilsson G, Forberg R, Öhrvik J, Malmberg K, Berne C et al. Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients. J Intern Med 2003; 254: 494-503.
17. Norhammar A, Tenerz Å, Nilsson G, Hamsten A, Efendic S, Rydén L et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140-2144.
18. Malmberg K for the DIGAMI (Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. Br Med J 1997; 314: 1512-1515.
19. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation 1999; 99: 2626-2632.
20. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367.
21. Norhammar A, Malmberg K, Rydén L, Tornvall P, Stenestrand U, Wallentin L, for the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions. Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003; 24: 838-844.